SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
5 references·1 citing·25 second hop
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries (2020)Availability and affordability of medicin…Medicine Shortages: Gaps Between Countries and Global Perspectives (2019)Medicine Shortages: Gaps Betw…Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study (2018)Availability and affordabilit…Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data (2015)Availability and affordabilit…Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data (2010)Availability, price and affor…The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries (2007)The availability and affordab…Associations of perceived built environment characteristics using NEWS questionnaires with all-cause mortality and major cardiovascular diseases: The prospective urban rural epidemiology (PURE)-China study (2024)Associations of perceived bui…Household catastrophic health expenditure: a multicountry analysis (2003)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Essential medicines for universal health coverage (2016)Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases (2016)The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review (2018)The household economic burden of non-communicable diseases in 18 countries (2020)World Development Indicators 2005 (2005)THE WORLD MEDICINES SITUATION 2011 (2011)Financial Risk Protection and Universal Health Coverage: Evidence and Measurement Challenges (2014)Projections of Global Mortality and Burden of Disease from 2002 to 2030 (2006)Essential Medicines Are More Available than Other Medicines around the Globe (2014)Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases (2017)Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability (2020)A scoping review of scoping reviews: advancing the approach and enhancing the consistency (2014)Pricing in the Market for Anticancer Drugs (2015)Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications (2020)Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications (2021)Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications (2021)Neighborhood Environment Walkability Scale (2006)Association Between Fear of Crime and Mental Health and Physical Functioning (2007)Data driven assessment of built environment impacts on urban health across United States cities (2025)The association of neighborhood walkability and food environment with incident cardiovascular disease in The Maastricht Study (2025)Insulin prices, availability and affordability in 13 low-income and middle-income countries (2019)Global accessibility of therapeutics for diabetes mellitus (2022)A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries (2024)
this work references cited by second hop

References

  • 2007The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries487 cited
  • 2015Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data393 cited
  • 2018Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study203 cited
  • 2010Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data180 cited
  • 2019Medicine Shortages: Gaps Between Countries and Global Perspectives147 cited

Cited by

  • 2024Associations of perceived built environment characteristics using NEWS questionnaires with all-cause mortality and major cardiovascular diseases: The prospective urban rural epidemiology (PURE)-China study11 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work